ES9000011A1 - Procedimiento para transformar un cultivo de celulas de modo que produzca activador de plasminogeno de tejido (t-pa) humano - Google Patents

Procedimiento para transformar un cultivo de celulas de modo que produzca activador de plasminogeno de tejido (t-pa) humano

Info

Publication number
ES9000011A1
ES9000011A1 ES557800A ES557800A ES9000011A1 ES 9000011 A1 ES9000011 A1 ES 9000011A1 ES 557800 A ES557800 A ES 557800A ES 557800 A ES557800 A ES 557800A ES 9000011 A1 ES9000011 A1 ES 9000011A1
Authority
ES
Spain
Prior art keywords
mutants
tissue plasminogen
compositions
methods
plasminogen activator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES557800A
Other languages
English (en)
Other versions
ES557800A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ES557800A0 publication Critical patent/ES557800A0/es
Publication of ES9000011A1 publication Critical patent/ES9000011A1/es
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

COMPRENDE LAS SIGUIENTES OPERACIONES: 1. MEZCLAR EL CULTIVO DE CELULAS CON UN VECTOR DE EXPRESION REPLICABLE CAPAZ DE EXPRESAR, EN UNA CELULA HOSPEDANTE TRASFORMABLE, LA SECUENCIA DE ADN QUE CODIFICA LOS MUTANTES DEL ACTIVADOR DE PLASMINOGENO DE TEJIDO HUMANO OBTENIDOS EMPLEANDO MUTAGENESIS DIRIGIDA A UN LUGAR; 2. APORTAR A LA MEZCLA DE CULTIVO LOS NUTRIENTES NECESARIOS PARA EL CRECIMIENTO DE LAS CELULAS; 3. DEJAR QUE EL CULTIVO DE CELULAS SE DESENVUELVA EN LAS CONDICIONES DE CULTIVO USUALES.
ES557800A 1985-04-22 1988-01-15 Procedimiento para transformar un cultivo de celulas de modo que produzca activador de plasminogeno de tejido (t-pa) humano Expired - Fee Related ES9000011A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72546885A 1985-04-22 1985-04-22
US84669786A 1986-04-01 1986-04-01

Publications (2)

Publication Number Publication Date
ES557800A0 ES557800A0 (es) 1990-03-01
ES9000011A1 true ES9000011A1 (es) 1990-03-01

Family

ID=27111150

Family Applications (2)

Application Number Title Priority Date Filing Date
ES554251A Expired ES8802184A1 (es) 1985-04-22 1986-04-22 Procedimiento para la produccion de un mutante de activador de plasminogeno de tejido (t-pa) humano.
ES557800A Expired - Fee Related ES9000011A1 (es) 1985-04-22 1988-01-15 Procedimiento para transformar un cultivo de celulas de modo que produzca activador de plasminogeno de tejido (t-pa) humano

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES554251A Expired ES8802184A1 (es) 1985-04-22 1986-04-22 Procedimiento para la produccion de un mutante de activador de plasminogeno de tejido (t-pa) humano.

Country Status (21)

Country Link
US (1) US5147643A (es)
EP (1) EP0199574B1 (es)
JP (2) JPH0740940B2 (es)
AT (1) ATE68825T1 (es)
AU (1) AU596356B2 (es)
CA (1) CA1341580C (es)
DD (1) DD258026A5 (es)
DE (2) DE3613390C2 (es)
DK (1) DK175380B1 (es)
ES (2) ES8802184A1 (es)
FI (1) FI98930C (es)
FR (1) FR2581652B1 (es)
GB (1) GB2173804B (es)
GR (1) GR861037B (es)
HU (1) HU206520B (es)
IE (1) IE58574B1 (es)
IL (1) IL78571A (es)
MY (1) MY102550A (es)
NO (1) NO175216C (es)
NZ (1) NZ215920A (es)
PT (1) PT82429B (es)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58149871A (ja) * 1982-02-27 1983-09-06 本田技研工業株式会社 二，三輪車の盗難防止装置
JPS6087751A (ja) * 1983-10-20 1985-05-17 House Food Ind Co Ltd レトルト豆腐の製造法
EP0201153A3 (en) * 1985-02-09 1987-10-07 Beecham Group Plc Modified enzyme and process for its preparation
HUT41632A (en) * 1985-03-06 1987-05-28 Survival Technology Process for preparing agents for the enhancement of protein absorption
GR861037B (en) * 1985-04-22 1986-07-16 Genentech Inc Novel human tissue plasminogen activator mutants
US5736134A (en) * 1985-04-22 1998-04-07 Genentech, In.C Tissue plasminogen activator variants
US5756093A (en) * 1985-04-22 1998-05-26 Genentech, Inc. Tissue plasminogen activator variants
US4959318A (en) * 1985-06-27 1990-09-25 Zymogenetics, Inc. Expression of protein C
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
DE3684680D1 (de) * 1985-12-23 1992-05-07 Chiron Corp Peptidplasminogenaktivatoren.
DK43387A (da) * 1986-01-29 1987-07-30 Beecham Group Plc Fibrinolytisk enzym
US5837518A (en) * 1986-01-31 1998-11-17 Genetics Institute, Inc. Thrombolytic proteins
WO1987004722A1 (en) * 1986-01-31 1987-08-13 Genetics Institute, Inc. Novel thrombolytic proteins
US5071972A (en) * 1986-01-31 1991-12-10 Genetics Institute, Inc. DNA sequences encoding novel thrombolytic proteins
US5258298A (en) * 1986-01-31 1993-11-02 Genetics Institute, Inc. Deletion and glycosylation mutant of human tissue plasminogen activator
IE81073B1 (en) * 1986-03-18 2000-01-12 Genentech Inc Modified human tissue-type plasminogen activator and its preparation
US5589361A (en) * 1986-03-18 1996-12-31 Genentech, Inc. Human tissue-type plasminogen activator variant
AU7090887A (en) * 1986-04-02 1987-10-08 Beecham Group Plc Plasminogen activators modified in first kringle domain
PT84589B (en) * 1986-04-02 1989-05-09 Beecham Group Plc Process for preparing a fibrinolytic enzyme
US5169763A (en) * 1986-04-08 1992-12-08 Transgene S.A., Institut Pasteur Viral vector coding glycoprotein of HIV-1
GB8701811D0 (en) * 1987-01-28 1987-03-04 Beecham Group Plc Compounds
MY103358A (en) * 1987-04-15 1993-06-30 Novartis Ag Process for the production of protiens.
FI882407A (fi) * 1987-05-22 1988-11-23 Zymogenetics Inc Fibrinolytiska proteiner.
US5200340A (en) * 1987-05-22 1993-04-06 Zymogenetics, Inc. Thrombin-activated tissue plasminogen activators
DK302288A (da) * 1987-06-04 1989-02-03 Zymogenetics Inc Vaevsplasminogenaktivator med modificeret kringledomaene
DE3853100T2 (de) * 1987-06-04 1995-08-03 Zymogenetics Inc Gewebs-Plasminogen-Aktivator-Analoge mit modifizierten Wachstumsfaktordomänen.
WO1989000197A1 (en) * 1987-06-30 1989-01-12 Genentech, Inc. Improved processes for the treatment of vascular disease
US5302390A (en) * 1987-07-01 1994-04-12 Beecham Group Plc Hybrid proteins of human plasminogen and human t-PA, pharmaceutical compositions and methods of treatment
IL87276A (en) * 1987-08-03 1995-07-31 Fujisawa Pharmaceutical Co Analog of a tissue plasminogen activator containing the Pringle 2 and protease regions only, DNA encoding it, processes for its preparation, and pharmaceutical preparations containing it
JP2708749B2 (ja) * 1987-08-10 1998-02-04 エーザイ株式会社 修飾型ｔＰＡ含有注射用組成物
US5244676A (en) * 1987-10-09 1993-09-14 Monsanto Company Modified tissue plasminogen activator with modified glycosylation site
US4963357A (en) * 1987-10-09 1990-10-16 Monsanto Company Tissue plasminogen activator modified by the substitution of Arg for Cys at position 73, methods and pharmaceutical compositions therefor
US5037752A (en) * 1987-10-09 1991-08-06 Monsanto Company Modified tissue plasminogen activator substituted at cysteine-73 and lysine-277
EP0312346B1 (en) * 1987-10-16 1994-08-17 Genencor International, Inc. E. coli sequence specific acid protease
ATE125294T1 (de) * 1987-10-29 1995-08-15 Yamanouchi Pharma Co Ltd Polypeptid-verbindungen.
US5504001A (en) * 1987-11-25 1996-04-02 Zymogenetics, Inc. Hybrid plasminogen activator
US5094953A (en) * 1988-03-21 1992-03-10 Genentech, Inc. Human tissue plasminogen activator variants
WO1990001540A1 (en) * 1988-08-11 1990-02-22 California Biotechnology Inc. Method for stabilizing heterologous protein expression and vectors for use therein
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5258180A (en) * 1988-09-02 1993-11-02 Genetech, Inc. Tissue plasminogen activator having fibrin specific properties and deletion of amino acids 466-970, compositions and methods of treatment
US5087572A (en) * 1989-12-01 1992-02-11 Genentech, Inc. Dna encoding human plasminogen modified at the cleavage site
US5190756A (en) * 1989-12-01 1993-03-02 Genentech, Inc. Methods and materials for expression of human plasminogen variant
DE3942142A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von glykosyliertem t-pa
ATE145669T1 (de) * 1991-12-16 1996-12-15 Genentech Inc T-pa substitutionsvarianten mit verbesserter fibrinspezifität
CA2125403C (en) * 1991-12-16 2002-08-27 Herbert L. Heyneker Novel tissue plasminogen activator variants
DK0643772T3 (da) * 1992-06-03 1998-02-02 Genentech Inc Glycosyleringsvarianter af vævsplasminogenaktivator med forbedrede terapeutiske egenskaber
GB2298821A (en) * 1995-03-15 1996-09-18 Prestek Ltd A ribbon winding mechanism
DK0827751T3 (da) * 1996-09-06 2003-03-31 Chemo Sero Therapeut Res Inst Medicinsk præparat indeholdende vævsplasminogenaktivator og nicotinamid
EP0950095A2 (en) * 1996-11-12 1999-10-20 The Scripps Research Institute TISSUE TYPE PLASMINOGEN ACTIVATOR (t-PA) VARIANTS: COMPOSITIONS AND METHODS OF USE
US6706504B1 (en) 1996-11-12 2004-03-16 The Scripps Research Institute Tissue type plasminogen activator (t-PA) variants: compositions and methods of use
US5837688A (en) * 1996-11-27 1998-11-17 Gelfand; Mathew I. Use of thrombolytic reagents for prevention of vascular disease
WO2002020802A1 (fr) 2000-09-04 2002-03-14 Hunan Royal Biotech Lignee cellulaire exprimant un activateur de plasminogene tissulaire humain mutant, procede de recombinaison et procede de preparation de la proteine exprimee
US7597895B2 (en) * 2001-02-20 2009-10-06 The Governing Council Of The University Of Toronto Signal peptides, nucleic acid molecules and methods for treatment of caries
US7556807B2 (en) 2001-02-20 2009-07-07 Kane Biotech, Inc. Signal peptides, nucleic acid molecules and methods for treatment of caries

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR241654A1 (es) * 1982-05-05 1992-10-30 Genentech Inc Procedimiento para producir activador de plasminogeno de tejido humano.
SU1662352A3 (ru) * 1982-05-05 1991-07-07 Генентек, Инк (Фирма) Штамм бактерий ЕSснеRIснIа coLI - продуцент активатора плазминогена тканевого типа
IL90047A (en) * 1982-10-19 1992-12-01 Cetus Oncology Corp Cysteine-depleted biologically active muteins other than interferon - '
US4753879A (en) * 1984-08-27 1988-06-28 Biogen N.V. Modified tissue plasminogen activators
EP0201153A3 (en) * 1985-02-09 1987-10-07 Beecham Group Plc Modified enzyme and process for its preparation
GR861037B (en) * 1985-04-22 1986-07-16 Genentech Inc Novel human tissue plasminogen activator mutants
DK43387A (da) * 1986-01-29 1987-07-30 Beecham Group Plc Fibrinolytisk enzym
WO1987004722A1 (en) * 1986-01-31 1987-08-13 Genetics Institute, Inc. Novel thrombolytic proteins

Also Published As

Publication number Publication date
JP2529816B2 (ja) 1996-09-04
DD258026A5 (de) 1988-07-06
ES554251A0 (es) 1988-04-16
AU596356B2 (en) 1990-05-03
JPH06277071A (ja) 1994-10-04
NO861559L (no) 1986-10-23
FR2581652A1 (fr) 1986-11-14
FI861673A (fi) 1986-10-23
DK181286D0 (da) 1986-04-21
GR861037B (en) 1986-07-16
GB2173804B (en) 1989-07-05
PT82429A (en) 1986-05-01
FR2581652B1 (fr) 1989-12-22
ATE68825T1 (de) 1991-11-15
HU206520B (en) 1992-11-30
EP0199574B1 (en) 1991-10-23
ES557800A0 (es) 1990-03-01
JPH0740940B2 (ja) 1995-05-10
IL78571A (en) 1991-06-30
DK181286A (da) 1986-10-23
JPS6224A (ja) 1987-01-06
EP0199574A3 (en) 1987-08-05
US5147643A (en) 1992-09-15
ES8802184A1 (es) 1988-04-16
EP0199574A2 (en) 1986-10-29
CA1341580C (en) 2008-09-30
AU5641686A (en) 1986-10-30
NO175216B (es) 1994-06-06
DE3613390C2 (de) 2001-10-11
DE3613390A1 (de) 1986-10-30
NO175216C (no) 1994-09-14
IE58574B1 (en) 1993-10-06
GB8609683D0 (en) 1986-05-29
FI98930C (fi) 1997-09-10
MY102550A (en) 1992-07-31
GB2173804A (en) 1986-10-22
HUT40703A (en) 1987-01-28
PT82429B (pt) 1988-03-03
IL78571A0 (en) 1986-08-31
DE3682104D1 (de) 1991-11-28
FI98930B (fi) 1997-05-30
NZ215920A (en) 1989-07-27
FI861673A0 (fi) 1986-04-21
DK175380B1 (da) 2004-09-20
IE861055L (en) 1986-10-22

Similar Documents

Publication Publication Date Title
ES9000011A1 (es) Procedimiento para transformar un cultivo de celulas de modo que produzca activador de plasminogeno de tejido (t-pa) humano
IL80659A0 (en) Modified tissue plasminogen activators,their preparation and pharmaceutical compositions containing them
GR3033146T3 (en) Modified polypeptides with increased biological activity
GEP20012448B (en) Tissue Plasminogen Activators (Improved Variants)
TW225532B (es)
ES8802537A1 (es) Un procedimiento para preparar una celula huesped con un vector de expresion correspondiente a un activante de plasminogenos de tipo tejido modificado.
ATE274588T1 (de) Mutante alpha-amylase mit zusätzlicher disulfidverbindung
GB2189249B (en) Modified human tissue-type plasminogen activator and its preparation
MY109990A (en) Microfluidised particles of atovaquone and pharmaceutical preparation thereof
HU9403343D0 (en) New pharmaceutical uses of krill enzymes
MY106202A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof.
IN183383B (es)
ES8605476A1 (es) Un procedimiento para preparar un derivado de acido benzoico.
AU1741088A (en) Mutant t-pa with kringle replacement
GR3002841T3 (en) 4-(1,2,5,6-tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines and 4-(hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamines
ES8707488A1 (es) Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona
AU7037987A (en) Oxygen generating herbicides synergized with detoxifying enzyme inhibitor
AU2804989A (en) Novel human tissue-type plasminogen activator variant
HU912742D0 (en) T-pa pro-stabilization
HUT63441A (en) Megakariocyte colony stimultating factor protein
AU586713B2 (en) Pharmaceutical composition having thrombolytic activity
MY102582A (en) 14, 15-substituted lanosterols and their use as hypocholesterolemic agents
AU103857S (en) Chair
AU7696087A (en) Recombinant human tissue plasminogen activator composition
AU117609S (en) Tool

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20100504